← Evidence map

ArticleBMC pharmacology & toxicology2022

Real-world safety of ulinastatin: a post-marketing surveillance of 11,252 patients in China.

Jin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35842685